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Abstract
Background: Six minute walk test (6 MWT) is a sub-maximal exercise test that measures an 
integrated response of all systems responsible during exercise. Pulmonary arterial hypertension 
(PAH) is a problem encountered by patients with atrial septal defect (ASD). Assessment of functional 
capacity in patients with PAH based on the WHO functional classifi cation remains a powerful 
predictor of survival in these patients. The World Health Organization functional classifi cation is a 
subjective tool because it is based on anamnesis of ordinary activity.  On the contrary, 6 MWT is 
an objective tool to measure functional capacity of patients with pulmonary hypertension.
Objective: To determine the walking distance obtained using 6 MWT as a measurement of functional 
capacity in ASD patients with PAH.
Methods: A cross sectional study was used to determine the walking distance as a measurement of 
functional capacity in ASD patient with PAH. This study was a sub-study of an Atrial Septal Defect 
Registry done in RSUP Dr. Sardijto, Yogyakarta, since 2012. Pulmonary arterial pressure was 
measured using Pulmonary Arterial Systolic Pressure (PASP) obtained from echocardiography. 
Pulmonary hypertension was divided into three categories based on PASP, mild with PASP of 
less than 45 mmHg, moderate with PASP of 45-59 mmHg and severe with PASP of more than 60 
mmHg. All patients did 6 MWT to measure their functional capacity. The relationship between 6 
MWT distance and severity of PAH was measured using Pearson correlation analysis.
Results: Forty-three patients were included in this study with 32 female patients (74%) and 11 
male patients (26%) with an age range of 17-70 years old. Forty-four patients (44%) with ASD 
had severe PAH. The mean of 6 MWT distance was 337 m. There were signifi cant differences 
between mild, moderate and severe PAH in correlation with the 6 MWT distance (p= 0.001). The 
patients with severe PAH had only 278 m walking distance compared to those with mild PAH who 
had 394 m walking distance. There was a signifi cant relationship between the 6 MWT distance and 
severity of PAH (p=0.01). This study showed that 6 MWT correlates negatively with the severity of 
PAH. We found that the higher pulmonary arterial pressure, the shorter walking distance (p=0.01, 
r -0,506). 
Conclusion: ASD defect patients with severe PAH had shorter walking distance compared to 
those with mild PAH. The 6 MWT is a reliable and objective measurement of functional capacity 
for ASD patients with PAH. 
Background
Assessment of functional capacity is 
traditionally done using anamnesis. However, 
anamnesis sometimes causes overestimation 
or underestimations of patients’ true functional 
capacity. Objective measurement is usually better 
than subjective measurement. There are many 
modalities to assess functional exercise capacity; 
one of which is a ‘6 Minute Walk Test’ (6 MWT). The 
‘6 Minute Walk Test’ is a simple test using 100 feet 
hallway without exercise equipment or advanced 
training for technicians. This test evaluates the 
global and integrated responses of all the systems 
involved during exercise, including pulmonary 
and cardiovascular systems, systemic circulation, 
peripheral circulation, blood, neuromuscular units 
and muscle metabolism.1
Atrial septal defect (ASD) is an acyanotic 
congenital heart defect with minimal symptoms 
that can cause delay in diagnosis until adulthood. 
Hence, ASD is the most frequent congenital heart 
defect in adult.2 Generally, patients come to see 
a doctor due to the development of pulmonary 
arterial hypertension (PAH). Assessment of 
functional capacity in ASD patients with PAH 
can help predict their survival. Pulmonary arterial 
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hypertension (PAH) functional classification 
using symptoms was determined by the World 
Health Organization (WHO) in 1998. Patients 
with WHO class IV have median survival of 6 
months compared to 6 years for WHO class I 
and II.3
The use of 6 MWT in PAH is to determine 
prognosis and post therapy assessment and daily 
activity assessment is used to determine functional 
classification. Assessment of daily activity is 
subjective and variative measurement.
The objective of this study was to determine 
functional capacity of ASD patients with PAH using 
a 6 MWT. By using 6 MWT, we can measure 
functional capacity and determine functional 
classifi cation and prognosis of ASD patients with 
PAH.
Methods 
This was a cross-sectional study, sub-study 
using data obtained from Atrial Septal Defect 
Registry of RSUP Dr. Sardjito, Yogyakarta. 
The inclusion criteria were ASD patients with 
PAH and within the age of 17-70 years. The 
exclusion criteria were ASD patients with PAH 
of other cause and who were unable to follow 6 
MWT. The assessment of PAH was done using 
echocardiography with Pulmonary Arterial Systolic 
Pressure (PASP). There were three groups of PAH 
using PASP, namely mild, moderate, and severe 
PAH, determined respectively when the PASP 
obtained was less than 45 mmHg, between 45 to 
59 mmHg, and more than 60 mmHg.
The 6 MWT was done by the examiner 
in Rehabilitation Centre of RSUP Dr. Sardjito, 
Yogyakarta. The location of the test was a closed 
hallway with 20 meters tract. Each turn was given a 
mark to ease patients in determining the turn. The 
assessment of Borg Scale and walking distance 
was measured during 6 MWT.
Results
There were 43 patients in this study, 
consisting of 32 female patients (74%) and 11 
male patients (26%). The mean age of ASD 
patients was 39.8 years (17-70 years). The mean 
size of the defect was 2.58 millimeters (mm). The 
mean of right ventricular (RV) enlargement was 
45.19 mm (30-66 mm). The mean PASP was 
72.9 mmHg (25-182 mmHg). Table 1 shows the 
baseline characteristics of the patients.
The proportion of ASD patients with PAH 
obtained in this study was that 19 patients (44%) 
had severe PAH with PASP less than 60 mmHg. 
Moderate PAH was experienced by 30% of the 
patients and 26% patients had mild PAH. Figure 
1 shows the proportion of ASD with PAH in this 
study.
Figure 1. Proportion of PH in ASD patients
From 6 MWT, walking distance data was 
obtained from ASD patients with mild, moderate 
and severe PAH. The mean walking distance was 
337 m with the shortest walking distance 134 m. 
In ASD patients with mild, moderate, and severe 
PAH, the mean walking distance was 394 m, 370 
m and 278 m, respectively (p=0.001). Figure 2 
Table 1.  Baseline characteristics of ASD patients 
with PAH
Category Mean Value
Age (years) 39.8 (17-70)
Atrial septal defect diameter (mm) 2.58 (0.4-4.3)
Right ventricular diameter (mm) 45.19 (30-66)
Pulmonary arterial pressure (mmHg) 72.9 (25-182)
Six minute walk test walking 
distance (m)
337.19 (134-
800)
O2 arterial saturation (%) 95.7 (79-99)
Figure 2. Mean 6 MWT distance between ASD 
patients with mild, moderate and severe 
PAH (p=0.001).
mild PH
moderate PH
severe PH
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shows the mean walking distance in ASD patients 
with mild, moderate and severe PAH.
Pearson correlation test was done to 
determine the correlation between PASP and 
walking distance in 6 MWT. There was a signifi cant 
correlation between PASP and 6 MWT (p=0.01, 
r -0.506). Figure 3 shows a negative correlation 
between PASP and the mean walking distance 
in 6 MWT.
Figure 3.  Relation between pulmonary arterial 
pressure and 6 MWT distance (p=0.01, 
r -0.506)
Discussion
Atrial septal defect diagnosed in adulthood 
usually has already accompanied with PAH. 
Pulmonary arterial hypertension is an important risk 
factor in ASD because its severity  can complicate the 
decision to perform correction.5 In adult patients with 
uncorrected ASD, PAH will develop in the second 
or third decades.6 The mean age of ASD patients in 
this study was 39.8 years and in this age PAH would 
likely develop. The proportion of ASD patients with 
PAH in this study was 44% with the mean PASP of 
72.9 mmHg. In severe PAH, symptoms of activity 
intolerance would also appear.
The ‘6 Minute Walk Test’ is a submaximal test 
for patients that cannot tolerate well with exercise. 
Patients with PAH caused by ASD are a group of 
patients that need assessment of functional capacity 
for correction decision and evaluation of therapy. 
In general, the 6 MWT is a simple, affordable, and 
standardized tool for evaluating patient with PAH. 
The parameters that can be used are walking 
distance, oxygen saturation and Borg scale to 
assess dyspnea on activity.3 In this study, we found 
a negative and signifi cant correlation between PASP 
and walking distance obtained using 6 MWT. This 
result showed that an increase in severity of PAH 
caused a decrease of walking distance in 6 MWT.
The patients with severe PAH in this study 
showed the mean walking distance of 278 m. This 
was signifi cantly different between the patients with 
mild PAH that obtained the mean walking distance of 
394 m. Prognosis of patients with PAH will decrease 
in walking distance less than 300 m. Guidelines on 
PAH classify this condition as unstable and have 
possibility to deterioriate.3 Other conditions that 
correlate with worse prognosis are the worsening 
conditions of functional classifi cation from WHO II 
to III or from III to IV. Objectively, PAH patients with 
walking distance less than 300 m are classifi ed as 
PAH with WHO III-IV. This shows that 6 MWT can 
be used as an objective tool to determine functional 
classifi cation other than self-report.
The disadvantage of using 6 MWT as exercise 
test is that patients’ motivation infl uences the test 
result. Age, sex, and adequate standardization 
from exercise test protocol and motivation to the 
patient can determine the result 6 MWT.
Conclusion
There was a negative correlation between 
severity of PAH and walking distance in patients 
with ASD. Six Minute Walk Test is a simple and 
affordable test and can objectively help determine 
functional capacity and functional classifi cation of 
ASD patients with PAH.
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